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Human tumorigenesis is associated with the accumulation of
mutations in oncogenes and in tumour suppressor genes (Fearon
and Vogelstein, 1990). Mutations in the adenomatous polyposis
coli (APC) tumour suppressor gene occur in the germline of
patients with familial adenomatous polyposis (FAP), an inherited
disease predisposing to colorectal cancers (Groden et al, 1991;
Miyoshi et al, 1992). The majority of colorectal cancers are,
however, sporadic, occurring in patients without FAP and in the
majority of such cases mutations occur (Powell et al, 1992).
Almost all APC mutations disrupt the coding sequence in the 3¢
half of APC (Miyoshi et al, 1992; Powell et al, 1992) producing
truncated APC proteins (Smith et al, 1993), implying that trun-
cated APC proteins may promote tumour cell growth.
Both wild-type and mutant APC proteins (Su et al, 1993;
Rubinfield et al, 1995) interact with the E-cadherin associated
proteins a- and b-catenin. However only wild-type APC is able
to down-regulate b-catenin by enhancing degradation when
expressed exogenously in colon cancer cells (Munemitsu et al,
1995). This activity is localized between amino acid residues
1020–1169 (Su et al, 1993), which are absent in mutant APC,
implying that this region is essential for the down-regulation of
b-catenin and regulation of cell growth.
In mammalian systems, transfection of wnt 1 into PC12, AtT20
and C57MG cells leads to an accumulation of catenins (Hinck
et al, 1994), and recently Papkoff et al (Papkoff et al, 1996) have
shown that in C57MG cells exogenous wnt 1 results in accumula-
tion of monomeric catenins together with stabilization of the
APC–catenin complex. Antagonists also regulate this pathway.
Exogenous expression of axin, the gene product of the mouse
fused gene (Zeng et al, 1997) results in a reduction in b-catenin
levels in SW 480 colon cancer cells (Hart et al, 1998; Nakamura
et al, 1998). Furthermore, Hart et al (1998) showed that axin forms
a tetrameric complex with glycogen synthase kinase 3b (GSK3b),
b-catenin and APC resulting in increased phosphorylation of both
APC and b-catenin and ultimately leading to increased b-catenin
degradation. The region of APC necessary for binding to axin is
deleted in the truncated APC mutants found in colon cancer (Hart
et al, 1998).
Activation of the wnt-signalling pathway inhibits GSK3b
activity resulting in stabilization of monomeric b-catenin pools
(Papkoff et al, 1996), which are then able to associate with T-cell
factor (Tcf) transcription factor to enhance transcription of, as yet,
unknown genes (Korinek et al, 1997). Pennica et al (1999) have
shown that, in C57MG cells transfected with wnt 1, there is up-
regulation of two genes, WISP-1 and Wisp-2, and furthermore in
84% of a series of human colorectal tumours WISP-1 mRNA was
overexpressed when compared with patient-matched normal
mucosa. This wnt stabilization of b-catenin pools is analogous to
the situations produced either by truncations in the APC gene
product (Munemitsu et al, 1995) or by mutations in serine/
threonine phosphorylation sites in b-catenin (Morin et al, 1997).
Mutations in APC are, however, present in adenomas and there-
fore further changes are required to progress to carcinoma. A
second APC gene, named APCL or APC2, has recently been
cloned (Nakagawa et al, 1998; van Es et al, 1999) and shown to be
involved in controlling b-catenin–Tcf-mediated transcription (van
Es, 1999).
Studies in the nematode, Caenorhabditis elegans (Rocheleau
et al, 1997), have led to the identification of a set of maternally
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expressed genes, which are related to genes of the wnt-mediated
signalling pathway. They showed that mutations in these novel
genes disrupted normal embryonic endoderm induction resulting
in an abnormal gut phenotype. In Drosophila posterior midgut
morphogenesis the diffusible polypeptides, wnt 1 and decapenta-
plegic (Dpp, a member of the transforming growth factor b (TGF-
b) family) modulate activation of genes under control of the HOX
gene, abdomenal A (abd A) (Bilder et al, 1998). If a wnt-like
pathway is important in normal gut development subsequent
alterations in this pathway may be involved in colonic tumour
progression.
We previously showed that wnts 2, 4, 5a and 7b are up-regulated
in diseased states of human breast tissue (Huguet et al, 1994;
LeJeune et al, 1995). In the present study we have analysed
matched normal, adenomatous and malignant tissues taken from
each of 14 patients with colon cancer. The expression of eight wnt
genes have been quantified by RNAase protection analysis and
genes differentially up-regulated localized by in-situ mRNA
analysis. Additionally a range of colon adenoma and carcinoma
cell lines were analysed to assess wnt expression in vitro models
of human colon cancer.
MATERIALS AND METHODS
Tissue samples
Matched normal, adenomatous and malignant tissues were each
resected from 14 patients at the John Radcliffe Hospital, Oxford.
Normal samples were removed from sites greater than 2 cm distant
from the carcinoma, and adenoma samples were removed from
sites greater than 1 cm from the carcinoma. All samples were
carried to the laboratory on ice whereupon they were examined
by a pathologist, snap-frozen and stored at –196°C until used.
The samples were from independent lesions and assessed
pathologically to ensure that they were distinct adenomas or
carcinomas.
RNA preparation
Ribonucleic acid was extracted from tissues using the acid guani-
dinium thiocyanate phenol chloroform method (Chomczynski
et al, 1987). Aliquots (2 mg) of RNA were electrophoresed through
1% agarose gels and only those preparations with a 28S:18S
ribosomal ratio of approximately 2 were used for further analysis.
RNAase protection analysis
In all assays, 10 mg of total RNA were hybridized overnight at
55°C with a cocktail containing: 105 cpm of [a-32P]CTP-labelled
wnt antisense riboprobe, 5 ´ 104 cpm of [a-32P]CTP-labelled
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antisense
riboprobe, 2 ´ 103 cpm of [a-32P]CTP-labelled GAPDH sense
riboprobe and 20 mg carrier tRNA.
In quantifying ribonuclease protection data GAPDH is
commonly used as an internal control to standardize for losses
during the experiment. However, GAPDH is not a reliable internal
control when assaying mRNA expression in tumours. A more
accurate method of standardization is to include [a32P]CTP-
labelled sense and antisense GAPDH in the ratio 1:20 (counts
per minute) in the hybridization cocktail (Scott et al, 1997).
Quantitation of the exogenous GAPDH sense–antisense mRNA
duplex provides a more accurate determination of losses during
the procedure in addition to providing a measure of the endo-
genous GAPDH, which is also quantitatively detected on the gel.
In order to ensure that equal amounts of tissue RNA were taken
for hybridization, total RNA samples were measured spectro-
photometrically and the values obtained were then confirmed by
analysing 2-mg aliquots by agarose gel electrophoresis and visual-
ization of the 18S and 28S ribosomal RNAs.
Protected fragments were separated on 6% acrylamide/urea
sequence gels and subsequently exposed to X-ray film at –80°C
with intensifying screens. Exposure times varied between 1 h
(GAPDH signal) and 14 days (low abundance wnt signals).
Signals were quantified using either a Bioimage analyser
(Millipore) or a Phosphorimager 425 (Molecular Dynamics).
Construction of RNAase protection templates
Riboprobe templates for wnt 2 and wnt 3 were generated by PCR
amplification as described previously (Huguet et al, 1994) to give
fragments of 406 and 424 bp respectively. Wnt 4 and Wnt 7b ribo-
probe templates were isolated according to published procedures
(Gavin et al, 1990) and described in more detail (Huguet et al,
1994); fragment sizes were 360 and 372 bp respectively. A probe
template for wnt 11 was constructed by RT-PCR amplification of
human breast cancer RNA to give a fragment of 351 bp. A wnt 5a
riboprobe template was generated as described (LeJeune et al,
1995), giving a fragment of 384 bp and a wnt 10b probe template
was generated by PCR amplification resulting in a fragment of 370
bp (Bui et al, 1997b). The degree of homology between wnt ribo-
probes was sufficiently low enough to exclude any possibility of
each probe cross-hybridizing with other wnt family messenger
RNAs. The highly stringent conditions of the RNAase protection
assay, in conjunction with riboprobe design, also ensured no
cross-interference during analysis. A 120 bp fragment of human
GAPDH was cloned into plasmid pBluescript SK+. Antisense
[a-32P]CTP-labelled riboprobes were synthesized from their
linearized respective templates using the appropriate RNA
polymerase. In the case of GAPDH sense [a-32P]CTP-labelled
riboprobe was also synthesized.
Isolation of wnt 13 cDNA by RT-PCR
Heat denatured breast tumour RNA was reverse transcribed for 1 h
at 37°C in a 50 ml reaction volume containing 1 mg degenerate
reverse transcription (RT) oligonucleotide (5¢-GCAG/A
CACCAG/ATGG/A
A/TA-3¢), corresponding to amino acid wnt
consensus region FHWCC0 and 2.5 units murine reverse tran-
scriptase. Aliquots of reverse transcribed RNA and negative
controls were used in 50 ml polymerase chain reaction (PCR) reac-
tions containing 1 mg each of forward and reverse degenerate PCR
oligonucleotides (forward oligonucleotide corresponding to amino
acid wnt consensus region CKCHG; 5¢-TGT/CAAA/GTGT/CC-
AC/TGGG/A/T-3¢, reverse oligonucleotide corresponding to amino
acid wnt consensus region CCGRG; 5¢-G/CCCA/C/T/GCT/G
A/C/GC-
CG/ACAGCA-3¢). Five microlitres of the PCR reactions were
electrophoresed in a 2% agarose gel and DNA visualized by
ethidium bromide staining. Bands were cut out of the gel,
subcloned into the pCR®2 vector and sequenced by the dideoxynu-
cleotide chain termination method using a sequenaseR kit. The
sequence obtained by us matches that recently published (Katoh
et al, 1996).498 K Smith et al
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Cell lines and culture conditions
The following human colorectal adenocarcinoma cell lines were
used in this study: LOVO, SW620, SW837, SW480, COLO201
and HT29. The line HCT116 is a human colorectal carcinoma cell.
The lines AA/C1, RG/C2 and BH/C1 are adenoma cell lines,
whilst AA/C1/SB/10C is a chemically transformed tumorigenic
variant of the AA/C1 line. Breast HB2 cells were used as positive
control.
Cells were grown in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum in a humidified incubator
under 95% air, 5% carbon dioxide. RNA was extracted from cells
when approximately 50–70% confluent.
In situ hybridization
In situ hybridization was carried out essentially as described by
Senior et al (1988). Briefly, 4-mm sections were cut from formalin-
fixed, paraffin-embedded blocks on TESPA (7,3-aminopropyl-
triethoxy silane)-treated slides and dried overnight at 37°C.
Sections were permeabilized with proteinase-K, fixed in 4%
paraformaldehyde, air dried and hybridized overnight at 55°C with
106 cpm of [35S]UTP-labelled antisense riboprobes for wnt 2 and
wnt 5a in 10 ml hybridization buffer. The slides were washed
several times in 50% formamide–4 ´ standard saline citrate (SSC)
at 55°C to remove unhybridized probe, followed by RNAase treat-
ment to digest single-stranded and imperfectly hybridized domains
and washing extensively to a final stringency of 0.5 ´ SSC at 65°C
for 30 min. Slides were dipped in Ilford K5 emulsion and autoradi-
ographed at 4°C for 7 or 14 days. Latent images were developed
with Kodak D-19 and counterstained with Giemsa. As a positive
control for the presence of mRNA, sections were hybridized with a
b-actin antisense [35S]UTP-labelled riboprobe.
Immunochemical analysis of CD68 protein
Deparaffinized, rehydrated tissue sections were treated with 3%
hydrogen peroxide to quench endogenous peroxidase activity.
Sections were microwaved 4 min in citrate buffer, rinsed with
distilled water and placed in TBS for 5 min. Mouse monoclonal
anti-CD68 antibody, KP1 (Pulford et al, 1989) (Dako, Glostrup,
Denmark) in TBS–1% bovine serum albumin (BSA) was added
and incubated 30 min at room temperature. After washing in TBS,
streptABComplex/HRP conjugated to goat anti-mouse antibody
was added for 30 min room temperature. Sections were again
washed with TBS prior to development with diaminobenzidine as
chromagen. Slides were finally washed in distilled water, counter-
stained with haematoxylin and mounted in Apathy’s aqueous
medium.
Statistical analysis
Expression values of each wnt gene in matched normal, adenoma
and carcinoma samples from the same patient were compared
using Wilcoxon matched pairs sign test. The Mann–Whitney
U-test was used to compare expression values for each wnt gene
in normal, adenoma and carcinoma samples.
RESULTS
Patient characteristics
Normal, adenomatous and carcinomatous tissues were removed
from each of 14 patients with colorectal cancer. The mean and
median ages were both 69 years (range 54–82 years). Regional
nodes were sampled in all patients at the time of surgery. Eight
patients had involvement of lymph nodes. Three cancers were
rectal, two were caecal and nine were colonic. Three tumours were
well- and 11 were moderately differentiated. One tumour was
confirmed as Dukes’ stage A, 5 as Dukes’ stage B and 8 as Dukes’
stage C.
Sequence analysis of gene fragments amplified by
degenerate RT-PCR
Purification, cloning and sequencing of the fragments isolated
after RT-PCR resulted in the isolation of a novel wnt gene (wnt 13)
whose sequence together with its corresponding amino acid
sequence is in agreement with that recently reported (Katoh et al,
1996) (results not shown).
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Figure 1 Ribonuclease protection analysis showing wnt 2 gene expression
in colorectal tissues and cell lines. (A) wnt 2 and wnt 5a mRNA levels
together with corresponding GAPDH sense – antisense mRNA hybrid levels
(GAPDH 1) as loading control in nine matched normal, adenoma and tumour
specimens. The endogenous GAPDH mRNA levels for each sample are also
show (GAPDH 2). n = normal, a = adenoma and t = tumour RNAs
respectively. (B) wnt2 and wnt 5a mRNA levels (a), wnt 13 and wnt 10b
mRNA levels (b). GAPDH sense-antisense hybrid levels are shown as
loading controls. Tumour and HB 2 breast cell RNA samples were included
as positive controls. tRNA = transfer RNA was included as negative control.wnt gene in colorectal cancer 499
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Expression of wnt genes in human colorectal tissues
Figure 1A shows a representative RNAase protection analyses of
wnt 2 and wnt 5a in colorectal tissues. The results for all wnt
expression profiles are tabulated in Table 1. The median
wnt2 mRNA expression in tumours was up-regulated 28-fold
(P = 0.0001, Wilcoxon test) compared with normal and 19-fold
(P = 0.0002, Wilcoxon test) compared with adenomatous tissues.
In relation to the other wnt mRNAs analysed the message for
wnt 5a was most abundantly expressed. The carcinomas also had
higher levels of this message compared with normals (P = 0.0018,
Wilcoxon test) and with adenomas (P = 0.0129, Wilcoxon test).
Levels of wnt 5a were comparable to those observed in human
breast cancers (LeJeune et al, 1995). When the above data for wnt
2 and wnt 5a were re-analysed using the Mann–Whitney U-test
the differences remained statistically significant with very similar
P-values (data not shown).
Wnt 13 showed no differential regulation between carcinoma
and non-carcinoma samples, and the message levels for wnt 11
and wnt 10b were too low to be detected by RNAase protection
analysis. Wnt 7b expression was detected in one tumour sample
only (Table 1).
Expression of wnt genes in human colorectal cell lines
Figure 1B shows RNA protection analysis of wnt 2 and wnt 5a (a)
and of wnt 10b and wnt 13 (b). Table 2 depicts all wnt expression
profiles in 11 colorectal and one breast (HB2) cell lines. The abun-
dance of all wnt mRNAs was considerably less than in tissues, and
furthermore those wnt genes expressed in tissues were absent in
cell lines whilst wnt genes not expressed in tissues were expressed
in cells. Hence wnt 2, and to a lesser degree wnt 5a, which were
up-regulated in carcinomas compared to normal tissue were totally
absent in all colon cell lines analysed. Wnt 7b and wnt 10b, which
were absent (with one exception) in colorectal tissues, were
present, albeit at very low abundance in several carcinoma cell
lines. Wnt 13 mRNA was present in three colon carcinoma cell
lu
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Figure 2 In situ RNA hybridization of wnt 5a and anti-CD68 immunostaining
in human colorectal tissues. (A) Poorly differentiated carcinoma of large
bowel, light field. (B) Poorly differentiated carcinoma of large bowel, dark field
showing stromal areas with up-regulated wnt 5a expression. (C) Poorly
differentiated carcinoma of large bowel showing anti-CD68 immunostaining.
(D) Normal large bowel, light field. (E) Normal large bowel, dark field. (F)
Normal large bowel showing anti-CD68 immunostaining. Arrows indicate the
lamina propria containing wnt 5a-expressing macrophages; Lu=lumen;
SM=submucosa. All exposures were taken at ´285 magnification
Table 1 Wnt gene expression in matched normal, adenoma and carcinoma
specimens. Messenger RNA transcripts were assayed by RNase protection
assay. The values for the mean ± SD, median and range, in densitometric
units, and number of specimens are shown.
Wnt mRNA Normal Adenoma Carcinoma
Wnt 2 median 2.3 (n = 14) 3.4 (n = 14) 64.5 (n = 14)
range 0–4.7 0–26.2 2.0–1291.0
mean ± SD 1.83 ± 1.69 5.03 ± 6.73 168.7 ± 321.1
Wnt 3 median 0 (n = 9) 0(n = 9) 0.3 (n = 9)
range 0–0.1 0–0.5 0–3.5
mean ± SD 0.01 ± 0.02 0.06 ± 0.16 0.72 ± 1.12
Wnt 4 median 1.8 (n = 12) 5.8 (n = 13) 8.8 (n = 14)
range 0–27.1 0–22.6 0–51.8
mean ± SD 5.1 ± 8.0 6.4 ± 5.6 16.5 ± 17.2
Wnt 5a median 11.7 (n = 14) 26.2 (n = 14) 49.3 (n = 14)
range 1.1–50.6 0–100.2 5.9–178.5
mean ± SD 15.4 ± 12.5 32.7 ± 31.5 62.2 ± 48.0
Wnt 7a median N.D. (n = 5) N.D. (n = 5) N.D. (n = 5)
range
mean ± SD
Wnt 10b median N.D. (n = 5) N.D. (n = 5) N.D. (n = 5)
range
mean ± SD
Wnt 11 median N.D. (n = 5) N.D. (n = 5) N.D. (n = 5)
range
mean ± SD
Wnt 13 median 0 (n = 5) 0 (n = 5) 0 (n = 5)
range 0–3.6 0–0.2 0–1.7
mean ± SD 1.17 ± 1.38 0.03 ± 0.06 0.50 ± 0.66
N>D> = Not detected.500 K Smith et al
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lines as well as in tissues. No wnt gene expression was detected in
any of the adenoma cell lines (even after 14 days exposure).
In situ hybridization
Transcripts for both wnt 2 and wnt 5a were detected in several
colorectal tissues. The general level of expression of wnt 5a was
higher than that for wnt 2, which is in keeping with the RNAase
protection data where wnt 5a was clearly the most abundantly
expressed message. Background levels were higher for wnt 2. Wnt
5a labelling was predominantly present in the stroma/lamina
propria in normal, adenoma and carcinoma tissues. Representative
light (Figure 2A) and dark (Figure 2B) field exposures of a poorly
differentiated carcinoma of the large bowel show high expression
of wnt 5a in cells within stromal elements, and this was especially
clear near invasion fronts and ulcerated regions. Some of the posi-
tively staining cells appeared to be macrophages, whereas others
looked like fibroblasts. Figure 2D and E show representative light
and dark fields respectively of a section of normal large bowel
with wnt 5a expression in the lamina propria beneath the surface
epithelium. The only signals above background were in the
stroma, principally in cells between the tops of crypts. The
morphology of the positively labelled cells together with their
location beneath the surface epithelium in normal tissues indicated
them to be macrophages. Some positive cells appeared to be
stromal fibroblasts. However, it is not uncommon for macrophages
to assume a fibroblastic shape. The expression pattern for wnt 2
was similar to that seen for wnt 5a.
Immunostaining of the above sections with anti-CD 68 antibody
(Figure 2C, large bowel poorly differentiated carcinoma; and
Figure 2F, normal large bowel) identified the wnt-expressing cells
to be macrophages.
DISCUSSION
Wnt genes were initially isolated from mouse mammary carci-
nomas by insertional mutagenesis, but we have shown that they are
also up-regulated in human hormone-dependent cancers of the
breast (Huguet et al, 1994) and endometrium (Bui et al, 1997a).
Wnts are members of a multigene family with over 14 genes in
humans and most are conserved in Xenopus, suggesting specialized
roles for each gene product. We therefore examined the potential
role of wnts in progression from adenomas to carcinomas which
could be via wnt-induced inactivation of GSK-3b. The presence of
mutant APC gene products, which are unable to degrade b-catenin,
would also result in the elevation of monomeric b-catenin levels.
Support for this idea comes from a recent publication showing that
transfection of wild-type APC gene product into colon carcinoma
cells containing mutant APC removed b-catenin from Tcf-4 and
abrogated the transcriptional transactivation (Korinek et al, 1997).
Since in those colorectal cancers maintaining wild-type APC gene
product, wnt signalling could further enhance b-catenin levels.
Our results showed that wnt 2 was up-regulated 28-fold in
cancer samples. This contrasts with our studies of breast (Huguet
et al, 1994) and endometrial (Bui et al, 1997a) cancer where wnts
5a, 7b and 10b, but not wnt 2, were up-regulated. It may be that
several wnt genes are involved in the growth and development of
individual organs and each cancer type may exhibit a deregulation
in the expression of one or more wnt genes controlling normal
development within that organ. In colorectal cancer the situation is
further complicated, as discussed below, by the infiltration of
macrophages expressing relatively high levels of selected wnt
genes. While this work was in progress Vider et al (1996) showed
that, using RT-PCR, wnt 2 was up-regulated in colon cancer
compared with matching normal mucosa samples. In contrast to
our results they found that in seven adenomas from separate
patients wnt 2 expression was similar to that seen in carcinomas.
We are unsure as to why this is other than that different method-
ologies (RT-PCR opposed to RNAase protection and non-matched
samples compared to matched samples) were used. It is possible
that had Vider et al (1996) assayed expression levels in matching
carcinomas and adenomas the levels of wnt 2 may have been
considerably higher in the carcinoma compared to the adenoma.
Of interest is the observation that the range of wnt 2 expression
was far greater in our study compared to theirs. In addition, they
did not investigate the site of expression.
When adenoma and adenocarcinoma cell lines were studied for
expression of those wnt genes most markedly up-regulated in
colorectal carcinomas there was no detectable expression, in
contrast to the situation in breast and endometrial cancer cell
lines. This suggested that the up-regulation may be via a paracrine
pathway. In situ hybridization clearly showed expression of wnt 2
and wnt 5a in the stroma/lamina propria of normal, adenomatous
and carcinomatous colon samples. Immunohistochemical staining
with monoclonal antibodies to CD68 revealed that the majority of
positively labelled cells were macrophages, although some of the
positive cells had a fibroblast morphology. Our failure to assay
wnt 2 and wnt 5a expression in our panel of cell lines could be
explained on the basis that in the tissue samples expression of
these two genes was predominantly in infiltrating macrophages
and not in tissue epitheliums. Although this is the first report of
expression of wnt genes by macrophages or haemopoietic cells in
adults, it has recently been shown that foetal murine haemopoietic
tissues express wnts 1 and 5a (Austin et al, 1997). In addition,
wnts 1, 5a and 10b directly stimulate the proliferation of murine
liver haemopoietic stem/progenitor cell populations in culture,
thereby functioning as haemopoietic regulatory factors. Wnt gene
expression, overall, was very low in cell lines compared to
carcinomas. Of those genes expression there was little variation
between individual cell lines. This may imply that in these cell
lines wnt gene function can be mediated by similar gene
members.
Table 2 Wnt gene expression in colorectal adenoma and carcinoma cell
lines (for details see methods section) and in one breast cell (HB 2).
Messenger RNA transcripts were measured by RNase protection assay.
Levels were graded – (negative) through to +++ (strongly positive). 
Cell line Wnt2 Wnt4 Wnt 5a Wnt 7b Wnt 10b Wnt 13
HCT 116 – +/– – +/– – +
LOVO – +/– – + + +
SW 620 – +/– – +/– +/– –
SW 837 – +/– – +/– +/– +
COLO 201 – – – +/– – –
SW 480 – +/– +/– nd – –
HT 29 – nd – – – nd
AA/C1 – nd – – – nd
AA/C1/SB/10C – nd – – – nd
RG/C2 – nd – – – nd
BH/C1 – nd – – – nd
HB 2 – nd +++ ++ + nd
nd denotes not determined.Increased microphage infiltration into colon tumours compared
to normal mucosa was shown recently in a study involving
expression of the angiogenic enzyme thymidine phosphorylase
(Takebayashi et al, 1997). This enzyme was more highly expressed
in cancers primarily due to the inflammatory infiltrate. It is
possible that the presence of APC mutations in colorectal cancers,
resulting in elevated b-catenin pools, could increase signalling, via
b-catenin and cadherin, between malignant cells and infiltrating
macrophages leading to increased wnt 2 transcription. A correla-
tion between wnt 2 expression and APC status within colorectal
carcinomas would therefore be of interest. However, the up-regu-
lation of wnt 2 in inflammatory infiltrates is clearly not a general
mechanism leading to an increased expression in cancer since we
did not see it in endometrial cancers (Bui et al, 1997a). In breast
cancer there was a shift in compartmental expression between
epithelium and stroma, but no increase overall (Dale et al, 1996).
Thus macrophages in different sites may have different activation
or differentiation pathways.
It will be of interest to analyse stromal macrophage wnt 2
expression in co-culture with colon cells with and without APC
mutations and since wnt proteins are heparin-binding growth
factors they may be a target for therapy with heparin-like drugs.
The demonstration of a role for macrophages in two different path-
ways of colonic tumour progression, i.e. angiogenesis and the
wnt/APC/catenin pathway highlights their potential as a target for
drug therapy.
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